CGNT(CGNT)
CGNT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $446M | $492M | $453M |
| Low | $441M | $487M | $448M |
| High | $448M | $495M | $456M |
| EBITDA Avg | $-9M | $-10M | $-9M |
| Low | $-9M | $-10M | $-9M |
| High | $-9M | $-10M | $-9M |
| EBIT Avg | $-28M | $-31M | $-28M |
| Low | $-28M | $-31M | $-29M |
| High | $-28M | $-31M | $-28M |
| Net Income Avg | $33M | $56M | — |
| Low | $32M | $56M | — |
| High | $33M | $57M | — |
| EPS Avg | $0.45 | $0.77 | — |
| Low | $0.44 | $0.76 | — |
| High | $0.45 | $0.78 | — |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $109M | $113M | $119M | $116M | $119M | $125M | $132M |
| Low | $107M | $112M | $117M | $115M | $118M | $124M | $130M |
| High | $110M | $115M | $120M | $118M | $121M | $127M | $134M |
| EBITDA Avg | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M |
| Low | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M |
| High | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M |
| EBIT Avg | $-7M | $-7M | $-7M | $-7M | $-7M | $-8M | $-8M |
| Low | $-7M | $-7M | $-8M | $-7M | $-8M | $-8M | $-8M |
| High | $-7M | $-7M | $-7M | $-7M | $-7M | $-8M | $-8M |
| Net Income Avg | $6M | $11M | $13M | $12M | $13M | $14M | $18M |
| Low | $6M | $10M | $13M | $12M | $12M | $14M | $17M |
| High | $7M | $11M | $13M | $12M | $13M | $15M | $18M |
| EPS Avg | $0.09 | $0.14 | $0.18 | $0.16 | $0.17 | $0.20 | $0.24 |
| Low | $0.09 | $0.14 | $0.18 | $0.16 | $0.17 | $0.19 | $0.24 |
| High | $0.09 | $0.15 | $0.18 | $0.17 | $0.18 | $0.20 | $0.24 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |